Companies that manufacture, sell or dispense drugs in the European Union have until February 9, 2019 to comply. Where does the industry stand?
What President Trump's State of the Union rhetoric implies for pharma
A painless look inside the most impactful regulatory trends and actions from 2017
All the major changes this year including guidance documents drafted and finalized, new legislation, other areas of interest and some tools to help you explore additional areas not covered herein